• EXPLAINER: Why it's hard to make vaccines and boost supplies
    Washington, January 28 (AP): With demand for COVID-19 vaccines outpacing the world's supplies, a frustrated public and policymakers want to know: How can we get more? A lot more. Right away. The problem: It's not like adding more water to the soup, said vaccine specialist Maria Elena Bottazzi of Baylor College of Medicine. Makers of COVID-19 vaccines need everything to go right as they scale up production to hundreds of millions of doses and any little hiccup could cause
  • No indication Covid-19 variants can escape current vaccines: Expert
    New York, January 28 (IANS): Study so far has proved that the current vaccines remained effective against the variants of the Covid-19, which already infected over 100 million people worldwide, Case Western Reserve University's (CWRU) news portal on Wednesday quoted an expert as saying. "Unfortunately, several recent mutations appear to have been beneficial to the virus by increasing its ability to infect us at lower exposures. Fortunately, the vaccine companies have been s
  • PM Modi's govt set 'brilliant example' by providing vaccines to neighbours: B'desh minister
    New Delhi, January 21 (PTI): Countries in South Asia need to collaborate regionally and Prime Minister Narendra Modi's government has set a "brilliant example" by providing vaccines to India's neighbours, a Bangladeshi minister said on Thursday. Speaking at a webinar, Bangladesh's Minister of State for Foreign Affairs Mohammad Shahriar Alam said the South Asian Association for Regional Cooperation (SAARC) was "failing to live up to the expectations" a
  • World waiting for India's vaccines, watching how it runs world's biggest vaccination drive: PM
    New Delhi, January 9 (PTI): India is ready with two made-in-India vaccines for the protection of humanity and the world is not only waiting for them but also watching as to how the country runs the globe's biggest vaccination programme, Prime Minister Narendra Modi said on Saturday. In his address at the inauguration of the 16th Pravasi Bharatiya Divas (PBD) Convention, Modi also asserted that if democracy is most strong, vibrant and lively anywhere in the world, it is in India.
  • Now 'real hope' to end COVID-19 with vaccines: WHO chief
    Geneva, November 24 (IANS): "There is now real hope that vaccines, in combination with other tried and tested public health measures, will help to end the pandemic," said the World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus. The WHO chief's remarks came after drugmaker AstraZeneca said on Monday that its COVID-19 vaccine, developed with Oxford University, was up to 90 percent effective, making it the third major drug company after Pfizer and
  • Covid vaccine likely by early 2021; for old, high-risk first: Harsh Vardhan
    New Delhi, September 13 (IANS): The coronavirus vaccine might be ready by the first quarter of 2021, Union Health and Family Welfare Minister Harsh Vardhan said on Sunday. "While no date has been fixed for the vaccine launch, it may be ready by the first quarter of 2021," he said. Harsh Vardhan also said that the government is considering emergency authorisation of Covid-19 vaccination to senior citizens and people working in high-risk settings. "This shall be done
  • Experimental Covid-19 vax prevents severe disease in mice
    Washington, August 14 (IANS): An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study. The vaccine, which is made from a mild virus genetically modified to carry a key gene from the Covid-19 virus, is published in the journal Cell Host and Microbe. "Unlike many of the other vaccines under development, this vaccine is made from a virus that is capable of spreading in a limited fashion inside the human body, whic
  • ICMR aims to launch COVID-19 vaccine by Aug 15
    New Delhi, July 3 (PTI): Aiming to launch an indigenous COVID-19 vaccine by August 15, the Indian Council of Medical Research has written to select medical institutions and hospitals to fast-track clinical trial approvals for the vaccine candidate Covaxin being developed in collaboration with Bharat Biotech.   12 clinical trial sites have been identified at present and the apex health research body has asked the medical institutions and principal investigators to ensure that